Publication | Closed Access

Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma

UrologyOncologyPatients TreatedGenitourinary CancerPlus IpilimumabMedicinePharmacotherapyCancer TreatmentPharmacologyRenal PharmacologyKidney ResearchNivolumab Alone